DEX vs SEVO in Congenital Heart Surgery
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT05369949
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 150 participants
- Registry
-
NCT05369949
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT05369949. Randomized; no masking; primary purpose treatment. Start 2023-01-05 (anticipated); primary completion 2025-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DEX vs SEVO in Congenital Heart Surgery
- Acronym
- DEXLOSNeuro
- Condition
- Heart Defects, Congenital
- Intervention (Drug)
- DEX group
- Intervention (Other)
- Control group
- Lead sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Record details
- Record id
cardio:ct-nct05369949- Content hash
6872ac575a8ffaf506fad51c2876aaa7093d325c4a7d294c28d1ab69a0fa73dc